Real world experience of bortezomib re-treatment for patients with multiple myeloma at first relapse

被引：3
作者：
Reyal, Yasmin [1 ,2 ]
Popat, Rakesh [1 ,2 ]
Cheesman, Simon [1 ]
Rismani, Ali [1 ]
D'Sa, Shirley [1 ]
Rabin, Neil [1 ]
Yong, Kwee [1 ,2 ]
机构：
[1] Univ Coll London Hosp NHS Trust, Dept Haematol, London, England
[2] UCL, Dept Haematol, UCL Canc Inst, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2017年 / 177卷 / 03期
关键词：
myeloma; myeloma therapy; relapse; bortezomib; STEM-CELL TRANSPLANTATION; DEXAMETHASONE; PHASE-2; TRIAL;
D O I：
10.1111/bjh.14086
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：495 / 497
页数：3
相关论文
共 10 条
[1]   Clinically relevant end points and new drug approvals for myeloma [J].
Anderson, K. C. ;
Kyle, R. A. ;
Rajkumar, S. V. ;
Stewart, A. K. ;
Weber, D. ;
Richardson, P. .
LEUKEMIA, 2008, 22 (02) :231-239
[2]   High-dose chemotherapy plus autologous stem-cell transplantation as consolidation therapy in patients with relapsed multiple myeloma after previous autologous stem-cell transplantation (NCRI Myeloma X Relapse [Intensive trial]): a randomised, open-label, phase 3 trial [J].
Cook, Gordon ;
Williams, Cathy ;
Brown, Julia M. ;
Cairns, David A. ;
Cavenagh, Jamie ;
Snowden, John A. ;
Ashcroft, A. John ;
Fletcher, Marie ;
Parrish, Chris ;
Yong, Kwee ;
Cavet, Jim ;
Hunter, Hanna ;
Bird, Jenny M. ;
Chalmers, Anna ;
O'Connor, Sheila ;
Drayson, Mark T. ;
Morris, Treen C. M. .
LANCET ONCOLOGY, 2014, 15 (08) :874-885
[3]   Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial [J].
Harousseau, Jean-Luc ;
Attal, Michel ;
Avet-Loiseau, Herve ;
Marit, Gerald ;
Caillot, Denis ;
Mohty, Mohamad ;
Lenain, Pascal ;
Hulin, Cyrille ;
Facon, Thierry ;
Casassus, Philippe ;
Michallet, Mauricette ;
Maisonneuve, Herve ;
Benboubker, Lotfi ;
Maloisel, Frederic ;
Petillon, Marie-Odile ;
Webb, Iain ;
Mathiot, Claire ;
Moreau, Philippe .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) :4621-4629
[4]   A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma [J].
Jagannath, S ;
Barlogie, B ;
Berenson, J ;
Siegel, D ;
Irwin, D ;
Richardson, PG ;
Niesvizky, R ;
Alexanian, R ;
Limentani, SA ;
Alsina, M ;
Adams, J ;
Kauffman, M ;
Esseltine, DL ;
Schenkein, DP ;
Anderson, KC .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (02) :165-172
[5]   Bortezomib Plus Melphalan and Prednisone Compared With Melphalan and Prednisone in Previously Untreated Multiple Myeloma: Updated Follow-Up and Impact of Subsequent Therapy in the Phase III VISTA Trial [J].
Mateos, Maria-Victoria ;
Richardson, Paul G. ;
Schlag, Rudolf ;
Khuageva, Nuriet K. ;
Dimopoulos, Meletios A. ;
Shpilberg, Ofer ;
Kropff, Martin ;
Spicka, Ivan ;
Petrucci, Maria T. ;
Palumbo, Antonio ;
Samoilova, Olga S. ;
Dmoszynska, Anna ;
Abdulkadyrov, Kudrat M. ;
Schots, Rik ;
Jiang, Bin ;
Esseltine, Dixie L. ;
Liu, Kevin ;
Cakana, Andrew ;
van de Velde, Helgi ;
San Miguel, Jesus F. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (13) :2259-2266
[6]   Efficacy and safety of bortezomib-based retreatment at the first relapse in multiple myeloma patients: A retrospective study [J].
Oriol, Albert ;
Giraldo, Pilar ;
Kotsianidis, Ioannis ;
Couturier, Catherine ;
Olie, Robert ;
Angermund, Ralf ;
Corso, Alessandro .
HEMATOLOGY, 2015, 20 (07) :405-409
[7]   A prospective, international phase 2 study of bortezomib retreatment in patients with relapsed multiple myeloma [J].
Petrucci, Maria T. ;
Giraldo, Pilar ;
Corradini, Paolo ;
Teixeira, Adriana ;
Dimopoulos, Meletios A. ;
Blau, Igor W. ;
Drach, Johannes ;
Angermund, Ralf ;
Allietta, Nathalie ;
Broer, Esther ;
Mitchell, Vivien ;
Blade, Joan .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 160 (05) :649-659
[8]   Bortezomib or high-dose dexamethasone for relapsed multiple myeloma [J].
Richardson, PG ;
Sonneveld, P ;
Schuster, MW ;
Irwin, D ;
Stadtmauer, EA ;
Facon, T ;
Harousseau, JL ;
Ben-Yehuda, D ;
Lonial, S ;
Goldschmidt, H ;
Reece, D ;
San-Miguel, JF ;
Bladé, J ;
Boccadoro, M ;
Cavenagh, J ;
Dalton, WS ;
Boral, AL ;
Esseltine, DL ;
Porter, JB ;
Schenkein, D ;
Anderson, KC .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (24) :2487-2498
[9]   Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma [J].
San Miguel, Jesus F. ;
Schlag, Rudolf ;
Khuageva, Nuriet K. ;
Dimopoulos, Meletios A. ;
Shpilberg, Ofer ;
Kropff, Martin ;
Spicka, Ivan ;
Petrucci, Maria T. ;
Palumbo, Antonio ;
Samoilova, Olga S. ;
Dmoszynska, Anna ;
Abdulkadyrov, Kudrat M. ;
Schots, Rik ;
Jiang, Bin ;
Mateos, Maria-Victoria ;
Anderson, Kenneth C. ;
Esseltine, Dixie L. ;
Liu, Kevin ;
Cakana, Andrew ;
van de Velde, Helgi ;
Richardson, Paul G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (09) :906-917
[10]   Retreatment with bortezomib alone or in combination for patients with multiple myeloma following an initial response to bortezomib [J].
Sood, Raman ;
Carloss, Harry ;
Kerr, Robert ;
Lopez, Jose ;
Lee, Martin ;
Druck, Mark ;
Walters, Ian B. ;
Noga, Stephen J. .
AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (10) :657-660
1